Seminars in Nuclear Medicine
Volume 35, Issue 4 , Pages 214-219 , October 2005

Update on 18F-Fluorodeoxyglucose/Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Imaging of Squamous Head and Neck Cancers

  • Yusuf Menda, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Yusuf Menda, MD, Department of Radiology 3858 JPP, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242.
    • ,
  • Michael M. Graham, MD, PhD

References 

  1. Schöder H , Yeung HWD . Positron emission imaging of head and neck cancer, including thyroid carcinoma . Semin Nucl Med . 2004;34:180–197
  2. Dammann F , Horger M , Mueller-Berg M , et al.   Rational diagnosis of squamous cell carcinoma of the head and neck region (Comparative evaluation of CT, MRI, and 18FDG PET) . AJR Am J Roentgenol . 2005;184:1326–1331
  3. Syed R , Bomanji JB , Nagabhushan N , et al.   Impact of combined (18)F-FDG PET/CT in head and neck tumours . Br J Cancer . 2005;92:1046–1050
  4. Hyde NC , Prvulovich E , Newman L , et al.   A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma (The role of sentinel node biopsy and positron emission tomography) . Oral Oncol . 2003;39:350–360
  5. Stoeckli SJ , Steinert H , Pfaltz M , et al.   Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma . Head Neck . 2002;24:345–349
  6. Civantos FJ , Gomez C , Duque C , et al.   Sentinel node biopsy in oral cavity cancer (Correlation with PET scan and immunohistochemistry) . Head Neck . 2003;25:1–9
  7. Brink I , Klenzner T , Krause T , et al.   Lymph node staging in extracranial head and neck cancer with FDG PET—appropriate uptake period and size-dependence of the results . Nuklearmedizin . 2002;41:108–113
  8. Kovacs AF , Dobert N , Gaa J , et al.   Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer . J Clin Oncol . 2004;22:3973–3980
  9. Teknos TN , Rosenthal EL , Lee D , et al.   Positron emission tomography in the evaluation of stage III and IV head and neck cancer . Head Neck . 2001;23:1056–1060
  10. Schwartz DL , Rajendran J , Yueh B , et al.   Staging of head and neck squamous cell cancer with extended-field FDG-PET . Arch Otolaryngol Head Neck Surg . 2003;129:1173–1178
  11. Goerres GW , Schmid DT , Gratz KW , et al.   Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity . Oral Oncol . 2003;39:547–551
  12. Sigg MB , Steinert H , Gratz K , et al.   Staging of head and neck tumors ([18F]fluorodeoxyglucose positron emission tomography compared with physical examination and conventional imaging modalities) . J Oral Maxillofac Surg . 2003;61:1022–1029
  13. Schwartz DL , Ford E , Rajendran J , et al.   FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma . Int J Radiat Oncol Biol Phys . 2005;61:129–136
  14. Allal AS , Slosman DO , Kebdani T , et al.   Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose . Int J Radiat Oncol Biol Phys . 2004;59:1295–1300
  15. Ciernik IF , Dizendorf E , Baumert BG , et al.   Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT) (a feasibility study) . Int J Radiat Oncol Biol Phys . 2003;57:853–863
  16. Paulino AC , Koshy M , Howell R , et al.   Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2005;61:1385–1392
  17. Paulino AC , Johnstone PA . FDG-PET in radiotherapy treatment planning (Pandora’s box?) . Int J Radiat Oncol Biol Phys . 2004;59:4–5
  18. Scarfone C , Lavely WC , Cmelak AJ , et al.   Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging . J Nucl Med . 2004;45:543–552
  19. Nishioka T , Shiga T , Shirato H , et al.   Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas . Int J Radiat Oncol Biol Phys . 2002;53:1051–1057
  20. Heron DE , Andrade RS , Flickinger J , et al.   Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers (a brief technical report) . Int J Radiat Oncol Biol Phys . 2004;60:1419–1424
  21. Schwartz DL , Ford EC , Rajendran J , et al.   FDG-PET/CT-guided intensity modulated head and neck radiotherapy (A pilot investigation) . Head Neck . 2005;27:478–487
  22. Grau C , Johansen LV , Jakobsen J , et al.   Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology . Radiother Oncol . 2000;55:121–129
  23. Mendenhall WM , Mancuso AA , Amdur RJ , et al.   Squamous cell carcinoma metastatic to the neck from an unknown head and neck primary site . Am J Otolaryngol . 2001;22:261–267
  24. Mendenhall WM , Mancuso AA , Parsons JT , et al.   Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site . Head Neck . 1998;20:739–744
  25. Rusthoven KE , Koshy M , Paulino AC . The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor . Cancer . 2004;101:2641–2649
  26. Wong WL , Saunders M . The impact of FDG PET on the management of occult primary head and neck tumours . Clin Oncol (R Coll Radiol) . 2003;15:461–466
  27. Fogarty GB , Peters LJ , Stewart J , et al.   The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor . Head Neck . 2003;25:138–145
  28. Johansen J , Eigtved A , Buchwald C , et al.   Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck (A Danish cohort study) . Laryngoscope . 2002;112:2009–2014
  29. Kresnik E , Mikosch P , Gallowitsch HJ , et al.   Evaluation of head and neck cancer with 18F-FDG PET (a comparison with conventional methods) . Eur J Nucl Med . 2001;28:816–821
  30. Jungehulsing M , Scheidhauer K , Damm M , et al.   2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation . Otolaryngol Head Neck Surg . 2000;123:294–301
  31. Greven KM , Keyes JW , Williams DW , et al.   Occult primary tumors of the head and neck (lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose) . Cancer . 1999;86:114–118
  32. Kole AC , Nieweg OE , Pruim J , et al.   Detection of unknown occult primary tumors using positron emission tomography . Cancer . 1998;82:1160–1166
  33. Gutzeit A , Antoch G , Kuhl H , et al.   Unknown primary tumors (Detection with dual-modality PET/CT—initial experience) . Radiology . 2005;234:227–234
  34. Klabbers BM , Lammertsma AA , Slotman BJ . The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer . Mol Imaging Biol . 2003;5:257–270
  35. Greven KM , Williams DW , McGuirt WF , et al.   Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer . Head Neck . 2001;23:942–946
  36. Kutler DI , Patel SG , Shah JP . The role of neck dissection following definitive chemoradiation . Oncology (Huntingt) . 2004;18:993–998
  37. Goerres GW , Schmid DT , Bandhauer F , et al.   Positron emission tomography in the early follow-up of advanced head and neck cancer . Arch Otolaryngol Head Neck Surg . 2004;130:105–109 discussion 120–121
  38. Nam SY , Lee SW , Im KC , et al.   Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET . Oral Oncol . 2005;41:390–395
  39. Ritoe SC , Krabbe PF , Kaanders JH , et al.   Value of routine follow-up for patients cured of laryngeal carcinoma . Cancer . 2004;101:1382–1389
  40. Rogers JW , Greven KM , McGuirt WF , et al.   Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? . Int J Radiat Oncol Biol Phys . 2004;58:694–697
  41. Yao M , Graham MM , Hoffman HT , et al.   The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma . Int J Radiat Oncol Biol Phys . 2004;59:1001–1010
  42. Porceddu SV , Jarmolowski E , Hicks RJ , et al.   Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer . Head Neck . 2005;27:175–181
  43. Yao M , Graham MM , Smith RB , et al.   Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment (a preliminary report) . Int J Radiat Oncol Biol Phys . 2004;60:1410–1418

PII: S0001-2998(05)00027-9

doi: 10.1053/j.semnuclmed.2005.05.001

Seminars in Nuclear Medicine
Volume 35, Issue 4 , Pages 214-219 , October 2005

Article Tools